Home Procurement NewsAbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion

AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion

December 6, 2023•

The deal is AbbVie’s latest attempt to expand its drug pipeline as its top-selling treatments, such as Humira, face generic competition.

Was this article helpful?

YesNo

Last modified: December 6, 2023

Previous: EFCC closes case against ex-governor Suswam in N3.1 billion fraud trial

Next: Ondo is not better off with Tinubu’s intervention

Are you ready to join the Community?

Join the Conversation!

Community of Practice Portal aims to bring together key stakeholders in the procurement landscape in Nigeria to leverage on each others skillset in relation to understanding Procurement data in a bid to use these data to create stories and to generate action from the government.

Community of practice platform is an initiative under Anti-Corruption Innovation Project, a UNDP funded Project in collaboration with Accountability lab Nigeria, and Open Contracting Partnerships